CORCEPT THERAPEUTICS, INC. v. TEVA PHARMACEUTICALS USA, INC. et al > Summary
Court Case Number 2:19-cv-05066
Filing Date Feb 8, 2019
Termination Date Feb 21, 2019
Court New Jersey District Court
Status Statistical Closing
JudgesSusan D. Wigenton, Cathy L. Waldor
Plaintiff
Defendant
Plaintiff Attorneys
8Corcept Therapeutics
Attorney Name: William C. Baton
Saul Ewing LLP
Corcept Therapeutics
Attorney Name: Charles M. Lizza
Saul Ewing LLP
Corcept Therapeutics
Attorney Name: David Leigh Moses
Saul Ewing LLP
Corcept Therapeutics
Attorney Name: Sarah A. Sullivan
Saul Ewing LLP
Corcept Therapeutics
Attorney Name: Dominic Cerrito
Quinn Emanuel Urquhart & Sullivan
Corcept Therapeutics
Attorney Name: Eric C. Stops
Quinn Emanuel Urquhart & Sullivan
Corcept Therapeutics
Attorney Name: Daniel C. Wiesner
Quinn Emanuel Urquhart & Sullivan
Corcept Therapeutics
Attorney Name: John P. Galanek
Quinn Emanuel Urquhart & Sullivan
Cause
15:1126 Patent Infringement
Related Patents
| Doc No | Title | Issue date |
|---|---|---|
| 10195214 | Concomitant administration of glucocorticoid receptor modulators and CYP3A inhibitors | Feb 5, 2019 |
| 10166242 | Optimizing mifepristone levels for Cushing's patients | Jan 1, 2019 |
| 10166243 | Optimizing mifepristone levels for cushing'S patients | Jan 1, 2019 |
| 09943526 | Optimizing mifepristone levels for cushing's patients | Apr 17, 2018 |
